96 related articles for article (PubMed ID: 4869441)
1. EEG voltage as an indicator of drug-induced changes in schizophrenia.
Bruck MA
Am J Psychiatry; 1968 May; 124(11):1591-5. PubMed ID: 4869441
[No Abstract] [Full Text] [Related]
2. Schizophrenic subtypes defined by response to drugs and placebo.
Goldberg SC; Mattsson NB
Dis Nerv Syst; 1968 May; 29(5):Suppl:153-8. PubMed ID: 4876985
[No Abstract] [Full Text] [Related]
3. An evaluation of some possible prognostic indicators of response to phenothiazine treatment of acute schizophrenic psychoses.
Reznikoff M; Toomey LC
Int J Neuropsychiatry; 1965 Aug; 1(4):352-8. PubMed ID: 4379396
[No Abstract] [Full Text] [Related]
4. Drug treatment in newly admitted schizophrenic patients.
Clark ML; Huber WK; Charalampous KD; Serafetinides EA; Trousdale W; Colmore JP
Arch Gen Psychiatry; 1971 Nov; 25(5):404-9. PubMed ID: 4943915
[No Abstract] [Full Text] [Related]
5. Letter: Fluphenazine with other antipsychotic drugs.
Chouinard G; Fontaine R
Am J Psychiatry; 1975 Jul; 132(7):760-1. PubMed ID: 1137032
[No Abstract] [Full Text] [Related]
6. Are antipsychotic drugs interchangeable?
Gardos G
J Nerv Ment Dis; 1974 Nov; 159(5):343-8. PubMed ID: 4612111
[No Abstract] [Full Text] [Related]
7. Prediction of improvement in schizophrenia under four phenothiazines.
Goldberg SC; Mattsson N; Cole JO; Klerman GL
Arch Gen Psychiatry; 1967 Jan; 16(1):107-17. PubMed ID: 6066689
[No Abstract] [Full Text] [Related]
8. Dopamine antagonism by thioridazine in schizophrenia.
Meltzer HY; Sachar EJ; Frantz AG
Biol Psychiatry; 1975 Feb; 10(1):53-7. PubMed ID: 1120175
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia.
Goodnick PJ; Tong C; Duncavage MB; Meltzer HY
Biol Psychiatry; 1983 Dec; 18(12):1485-8. PubMed ID: 6140962
[No Abstract] [Full Text] [Related]
10. Paranoid and withdrawal symptoms in schizophrenia: differential symptom reduction over time.
Goldberg SC; Schooler NR; Mattsson N
J Nerv Ment Dis; 1967 Aug; 145(2):158-62. PubMed ID: 4861752
[No Abstract] [Full Text] [Related]
11. High- and low-potency neuroleptics in elderly psychiatric patients.
Branchey MH; Lee JH; Amin R; Simpson GM
JAMA; 1978 May; 239(18):1860-2. PubMed ID: 347110
[TBL] [Abstract][Full Text] [Related]
12. [Differential indication for the use of neuroleptics].
Vinar O
Act Nerv Super (Praha); 1970 Jan; 12(1):1-11. PubMed ID: 4907389
[No Abstract] [Full Text] [Related]
13. Chlorpromazine, clotiapine and thioridazine--a comparative clinical trial on Bantu psychotic patients.
Van Wyk AJ; Marais GF
S Afr Med J; 1971 Aug; 45(34):945-7. PubMed ID: 4939661
[No Abstract] [Full Text] [Related]
14. Prolixin enanthate and thorazine-stelazine regimens in the treatment of schizophrenic patients. An experimental evaluation.
DeWolfe AS; Barrell RP; London L; Spaner FE
Psychosomatics; 1971; 12(3):186-90. PubMed ID: 4950862
[No Abstract] [Full Text] [Related]
15. Differences in clinical effects of three phenothiazines in "acute" schizophrenia.
Dis Nerv Syst; 1967 Jun; 28(6):369-83. PubMed ID: 5342391
[No Abstract] [Full Text] [Related]
16. [Depot-neuroleptics in the treatment of schizophrenia].
Schipper JA
Ned Tijdschr Geneeskd; 1971 Apr; 115(16):707-9. PubMed ID: 5551427
[No Abstract] [Full Text] [Related]
17. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Pires P; Drolet A; Cote M; Villeneuve R
Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
[No Abstract] [Full Text] [Related]
18. [A double-blind controlled study of the efficacy and side effects of thioridazine and chlorpromazine in schizophrenia].
Guo GY
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):300-2, 319-20. PubMed ID: 3234163
[No Abstract] [Full Text] [Related]
19. Temporal changes in handwriting size, level of premorbid social functioning and intellectural level during treatment in acute schizophrenics.
Downing RW; Ebert JN; Boruchow JK; Valentine JH
J Nerv Ment Dis; 1966 Jun; 142(6):526-33. PubMed ID: 5920205
[No Abstract] [Full Text] [Related]
20. [Treatment of schizophrenia with fluphenazine].
Kerzeniewski L; Puzynski S
Acta Neurol Psychiatr Belg; 1966 Mar; 66(3):213-7. PubMed ID: 4958235
[No Abstract] [Full Text] [Related]
[Next] [New Search]
